Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07053969 · ClinicalTrials.gov registry record · NA

The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness

A NA study of Missing Teeth and Mucositis, sponsored by The University of Texas Health Science Center at San Antonio.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT07053969 is a NA study of Missing Teeth and Mucositis that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 32 participants, above the 27-participant average among 4 other Missing Teeth trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07053969, a NA study of Missing Teeth and Mucositis, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

Scientists do research to answer important questions which might help change or improve the way we do things in the future. The investigators know that using Enamel Matrix Derivatives results in thicker gum tissues around teeth. This study will test to see if using EMD around implants results in thicker gum tissues around implants.

Interventions

  • DEVICE Enamel Matrix Derivative

Study Locations (1)

Texas

  • University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2025-08-31
Est. Completion 2027-09
Phase NA

What the Registry Record Tells You About NCT07053969

The ClinicalTrials.gov registry entry for NCT07053969 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 27-participant average among 4 other Missing Teeth trials with a reported enrollment target (19% higher). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Missing Teeth appearing as the primary indexed condition, and to 1 intervention - of which Enamel Matrix Derivative is the first listed.

NCT07053969 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07053969 about?

NCT07053969 is a clinical study titled "The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness". Scientists do research to answer important questions which might help change or improve the way we do things in the future. The investigators know that using Enamel Matrix Derivatives results in thicker gum tissues around teeth. This study will test to see if using EMD around implants results in th...

What is the current status of trial NCT07053969?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-08-31. Estimated completion is 2027-09.

What conditions does trial NCT07053969 study?

This clinical trial studies the following conditions: Missing Teeth, Mucositis, Periodontitis, Adult, Dental Implantation.

What interventions are being tested in trial NCT07053969?

The interventions under investigation include: Enamel Matrix Derivative (DEVICE).

Who is sponsoring clinical trial NCT07053969?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07053969 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Missing Teeth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.